Global Monkeypox Rapid Test Kit Market Growth 2026-2032
Description
The global Monkeypox Rapid Test Kit market size is predicted to grow from US$ 970 million in 2025 to US$ 1656 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032.
In 2024, global Monkeypox Rapid Test Kit production reached approximately 51.1 million kits, with an average global market price of around US$ 18 per kit. The gross profit margin of major manufacturers ranges between 40% and 60%, and single-line production capacity typically falls between 200,000 and 300,000 kits per year. Monkeypox rapid test kits are in-vitro diagnostic devices designed for the quick detection of the monkeypox virus (MPXV) antigen or antibodies in human samples such as serum, plasma, or swabs. Using immunochromatographic or lateral flow assay technology, these kits can provide results within 10–20 minutes, supporting early diagnosis and outbreak control. They are widely utilized in hospitals, laboratories, border checkpoints, and epidemic response centers.
The monkeypox rapid test kit market is expanding steadily due to recurring outbreaks, growing public awareness, and stronger disease surveillance systems established after the COVID-19 pandemic. Governments and healthcare providers are investing in rapid, field-deployable testing technologies to prevent transmission and improve patient management. Manufacturers are focusing on optimizing sensitivity and specificity while reducing false positives through improved monoclonal antibody design and membrane materials. The increasing use of point-of-care testing (POCT) platforms and digital data integration supports faster epidemiological response. Asia-Pacific and Africa are emerging as key growth regions due to higher prevalence and rising investment in diagnostic infrastructure. However, the market still faces challenges from regulatory variations across regions, limited cold-chain logistics in developing areas, and competition from PCR-based molecular testing. As production becomes more standardized and costs decrease, rapid test kits will remain an essential first-line diagnostic tool for outbreak containment.
LP Information, Inc. (LPI) ' newest research report, the “Monkeypox Rapid Test Kit Industry Forecast” looks at past sales and reviews total world Monkeypox Rapid Test Kit sales in 2025, providing a comprehensive analysis by region and market sector of projected Monkeypox Rapid Test Kit sales for 2026 through 2032. With Monkeypox Rapid Test Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monkeypox Rapid Test Kit industry.
This Insight Report provides a comprehensive analysis of the global Monkeypox Rapid Test Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monkeypox Rapid Test Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monkeypox Rapid Test Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monkeypox Rapid Test Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monkeypox Rapid Test Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Monkeypox Rapid Test Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Antigen Test
Antibody Test
Others
Segmentation by Application:
Clinical Diagnosis
Public Health Monitoring
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
JOYSBIO
Getein Biotech
VivaChek Biotech
DaAn Gene
Labnovation
AdvaCare Pharma
Virax Biolabs
Vitrosens Biotechnology
Genobio Pharmaceutical
Poclight
Nanjing Synthgene Medical Technology
Jiangsu Mole Bioscience
Hotgen
Goldsite Diagnostics
Aurora Biomed
Key Questions Addressed in this Report
What is the 10-year outlook for the global Monkeypox Rapid Test Kit market?
What factors are driving Monkeypox Rapid Test Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Monkeypox Rapid Test Kit market opportunities vary by end market size?
How does Monkeypox Rapid Test Kit break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
In 2024, global Monkeypox Rapid Test Kit production reached approximately 51.1 million kits, with an average global market price of around US$ 18 per kit. The gross profit margin of major manufacturers ranges between 40% and 60%, and single-line production capacity typically falls between 200,000 and 300,000 kits per year. Monkeypox rapid test kits are in-vitro diagnostic devices designed for the quick detection of the monkeypox virus (MPXV) antigen or antibodies in human samples such as serum, plasma, or swabs. Using immunochromatographic or lateral flow assay technology, these kits can provide results within 10–20 minutes, supporting early diagnosis and outbreak control. They are widely utilized in hospitals, laboratories, border checkpoints, and epidemic response centers.
The monkeypox rapid test kit market is expanding steadily due to recurring outbreaks, growing public awareness, and stronger disease surveillance systems established after the COVID-19 pandemic. Governments and healthcare providers are investing in rapid, field-deployable testing technologies to prevent transmission and improve patient management. Manufacturers are focusing on optimizing sensitivity and specificity while reducing false positives through improved monoclonal antibody design and membrane materials. The increasing use of point-of-care testing (POCT) platforms and digital data integration supports faster epidemiological response. Asia-Pacific and Africa are emerging as key growth regions due to higher prevalence and rising investment in diagnostic infrastructure. However, the market still faces challenges from regulatory variations across regions, limited cold-chain logistics in developing areas, and competition from PCR-based molecular testing. As production becomes more standardized and costs decrease, rapid test kits will remain an essential first-line diagnostic tool for outbreak containment.
LP Information, Inc. (LPI) ' newest research report, the “Monkeypox Rapid Test Kit Industry Forecast” looks at past sales and reviews total world Monkeypox Rapid Test Kit sales in 2025, providing a comprehensive analysis by region and market sector of projected Monkeypox Rapid Test Kit sales for 2026 through 2032. With Monkeypox Rapid Test Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monkeypox Rapid Test Kit industry.
This Insight Report provides a comprehensive analysis of the global Monkeypox Rapid Test Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monkeypox Rapid Test Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monkeypox Rapid Test Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monkeypox Rapid Test Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monkeypox Rapid Test Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Monkeypox Rapid Test Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Antigen Test
Antibody Test
Others
Segmentation by Application:
Clinical Diagnosis
Public Health Monitoring
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
JOYSBIO
Getein Biotech
VivaChek Biotech
DaAn Gene
Labnovation
AdvaCare Pharma
Virax Biolabs
Vitrosens Biotechnology
Genobio Pharmaceutical
Poclight
Nanjing Synthgene Medical Technology
Jiangsu Mole Bioscience
Hotgen
Goldsite Diagnostics
Aurora Biomed
Key Questions Addressed in this Report
What is the 10-year outlook for the global Monkeypox Rapid Test Kit market?
What factors are driving Monkeypox Rapid Test Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Monkeypox Rapid Test Kit market opportunities vary by end market size?
How does Monkeypox Rapid Test Kit break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
118 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Monkeypox Rapid Test Kit by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Monkeypox Rapid Test Kit by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
